{"filing":{"accession_number":"0001378325-26-000035","cik":"0001378325","ticker":"CV","company_name":"CapsoVision, Inc","form":"8-K","filing_date":"2026-08-13","report_date":"2026-08-13","primary_document":"cv-20260813.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1378325/000137832526000035/cv-20260813.htm"},"events":[{"id":27603,"run_id":25169,"accession_number":"0001378325-26-000035","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"CapsoVision entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald for an at-the-market offering program permitting sale of up to $100 million in common stock, representing a material capital-raising mechanism that will dilute existing shareholders.","company_name":"CapsoVision, Inc","ticker":"CV","filing_date":"2026-08-13","form":"8-K","submitted_at":null,"items":[{"id":29194,"accession_number":"0001378325-26-000035","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"CapsoVision entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald for an at-the-market offering program permitting sale of up to $100 million in common stock. This is a classic dilutive equity issuance under Rule 415(a)(4), disclosed under Item 1.01 as a material definitive agreement. The company retains discretion over timing and amount, but the agreement itself represents a material capital-raising mechanism that will dilute existing shareholders. The supplemental earnings release confirms the company's cash position of $9.1 million as of June 30, 2026, underscoring the financing need.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T03:03:06.549699+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":27604,"run_id":25169,"accession_number":"0001378325-26-000035","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"CapsoVision issued a press release announcing financial results for the fiscal quarter ended June 30, 2026, including quarterly revenue of $3.6 million (up 10% YoY), gross profit, operating expenses, net loss of $7.5 million, and per-share metrics, along with condensed financial statements.","company_name":"CapsoVision, Inc","ticker":"CV","filing_date":"2026-08-13","form":"8-K","submitted_at":null,"items":[{"id":29195,"accession_number":"0001378325-26-000035","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"CapsoVision issued a press release on August 13, 2026, announcing financial results for the fiscal quarter ended June 30, 2026. The disclosure includes quarterly revenue ($3.6 million, up 10% YoY), gross profit, operating expenses, net loss ($7.5 million), and per-share metrics, along with condensed financial statements (balance sheet, income statement, cash flows). This is a standard quarterly earnings release disclosed under Item 2.02, material to investors assessing the company's financial performance and trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T03:03:06.549699+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29194,"accession_number":"0001378325-26-000035","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"CapsoVision entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald for an at-the-market offering program permitting sale of up to $100 million in common stock. This is a classic dilutive equity issuance under Rule 415(a)(4), disclosed under Item 1.01 as a material definitive agreement. The company retains discretion over timing and amount, but the agreement itself represents a material capital-raising mechanism that will dilute existing shareholders. The supplemental earnings release confirms the company's cash position of $9.1 million as of June 30, 2026, underscoring the financing need.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T03:03:06.549699+00:00","company_name":"CapsoVision, Inc","ticker":"CV","filing_date":"2026-08-13"},{"id":29195,"accession_number":"0001378325-26-000035","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"CapsoVision issued a press release on August 13, 2026, announcing financial results for the fiscal quarter ended June 30, 2026. The disclosure includes quarterly revenue ($3.6 million, up 10% YoY), gross profit, operating expenses, net loss ($7.5 million), and per-share metrics, along with condensed financial statements (balance sheet, income statement, cash flows). This is a standard quarterly earnings release disclosed under Item 2.02, material to investors assessing the company's financial performance and trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T03:03:06.549699+00:00","company_name":"CapsoVision, Inc","ticker":"CV","filing_date":"2026-08-13"}]}